German Christopher Paul Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$70,357.50

Insider Activity of German Christopher Paul

According to the SEC Form 4 filings, German Christopher Paul, being in a position of

  1. Corporate Controller & CAO at Rhythm Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10257 shares for $930,921,
    over all time since 2024-04-02, has bought 0 shares, and sold 18990 shares for $1.59M.

Biography of German Christopher Paul

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $930,9212100

Comparison of Insiders on Amount of Buys and Sells

2026-05-15SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
4,643
0.0069%
$92.21$428,131+9.66%
2026-03-04SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
5,614
0.0083%
$89.56$502,790+2.18%
2025-08-12SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
1,500
0.0023%
$95.00$142,500+4.2%
2025-07-09SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
3,817
0.0054%
$80.75$308,217+10.66%
2025-06-10SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
2,069
0.0032%
$67.19$139,016+44.26%
2025-03-21SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
344
0.0006%
$54.23$18,655+86.8%
2025-02-19SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
635
0.001%
$57.22$36,335+65.9%
2024-04-02SaleRhythm Pharmaceuticals, Inc.
RYTM
Corporate Controller & CAO
368
0.0006%
$41.76$15,368+24.39%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.